Reportee | Signature Date | Report period | Total Entries | Total AUM($) |
---|---|---|---|---|
FORESITE CAPITAL MANAGEMENT IV LLC | 02-13-2024 | 12-31-2023 | 5 | 197,872,800 |
Issuer | Class | Position | Value | Shares | Portfolio Percentage (%) | Previous Percentage (%) | Shares Delta | Shares Delta(%) | Date Reported |
---|---|---|---|---|---|---|---|---|---|
Pharvaris N.V. | COM | 1 | $113,289,518 | 4,038,842 | 0.06 | 0.03 | 295,392 | 7.89 | 12-31-2023 |
Aclaris Therapeutics, Inc. | COM | Liquidated | $0 | 0 | 0.01 | 0.01 | 0 | 0.00 | 12-31-2023 |
Kura Oncology, Inc. | COM | 3 | $26,602,238 | 1,849,947 | 0.01 | 0.01 | 0 | 0.00 | 12-31-2023 |
Kinnate Biopharma Inc. | COM | 4 | $22,921,794 | 9,671,643 | 0.01 | 0.01 | 0 | 0.00 | 12-31-2023 |